Clinical Study on the Treatment of Type 2 Diabetes with BMPRP

Objective: To retrospectively analyze the effects of (bone marrow platelet-rich plasma BMPRP) precise pancreatic infusion therapy versus conventional treatment. Methods: Bone marrow was collected from the iliac crest anterior superior spine, and platelet-rich plasma was separated by centrifugation. BMPRP was infused into the pancreas under ultrasound guidance. It was compared with conventional hypoglycemic drugs and insulin therapy. Results: In the BMPRP treatment group of 32 cases, the fasting blood sugar and hemoglobin A1c were significantly lower than pre-treatment levels, while the C-peptide level did not change significantly. The insulin dose was reduced. In the conventional treatment group of 28 cases, the fasting blood sugar, hemoglobin A1c, and C-peptide levels did not change significantly after continuous treatment for one year, and the insulin dose was not reduced. Conclusion: BMPRP precise pancreatic infusion therapy can improve pancreatic function, reduce insulin resistance, lower blood sugar, and reduce the required insulin dosage.